載入...
Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
BACKGROUND: Acute lymphoblastic leukemia (ALL) is an aggressive malignant disorder of lymphoid progenitor cells in both children and adults. Although improvements in contemporary therapy and development of new treatment strategies have led to dramatic increases in the cure rate in children with ALL,...
Na minha lista:
| 發表在: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4757994/ https://ncbi.nlm.nih.gov/pubmed/26892465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0241-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|